Cargando…
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition
The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research ques...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587293/ https://www.ncbi.nlm.nih.gov/pubmed/37804479 http://dx.doi.org/10.1007/s12282-023-01505-x |
| _version_ | 1785123331133931520 |
|---|---|
| author | Terada, Mitsuo Ito, Aki Kikawa, Yuichiro Koizumi, Kei Naito, Yoichi Shimoi, Tatsunori Ishihara, Mikiya Yamanaka, Takashi Ozaki, Yukinori Hara, Fumikata Nakamura, Rikiya Hattori, Masaya Miyashita, Minoru Kondo, Naoto Yoshinami, Tetsuhiro Takada, Masahiro Matsumoto, Koji Narui, Kazukata Sasada, Shinsuke Iwamoto, Takayuki Hosoda, Mitsuchika Takano, Yuko Oba, Takaaki Sakai, Hitomi Murakami, Akari Higuchi, Toru Tsuchida, Junko Tanabe, Yuko Shigechi, Tomoko Tokuda, Emi Harao, Michiko Kashiwagi, Shinichiro Mase, Junichi Watanabe, Junichiro Nagai, Shigenori E. Yamauchi, Chikako Yamamoto, Yutaka Iwata, Hiroji Saji, Shigehira Toyama, Tatsuya |
| author_facet | Terada, Mitsuo Ito, Aki Kikawa, Yuichiro Koizumi, Kei Naito, Yoichi Shimoi, Tatsunori Ishihara, Mikiya Yamanaka, Takashi Ozaki, Yukinori Hara, Fumikata Nakamura, Rikiya Hattori, Masaya Miyashita, Minoru Kondo, Naoto Yoshinami, Tetsuhiro Takada, Masahiro Matsumoto, Koji Narui, Kazukata Sasada, Shinsuke Iwamoto, Takayuki Hosoda, Mitsuchika Takano, Yuko Oba, Takaaki Sakai, Hitomi Murakami, Akari Higuchi, Toru Tsuchida, Junko Tanabe, Yuko Shigechi, Tomoko Tokuda, Emi Harao, Michiko Kashiwagi, Shinichiro Mase, Junichi Watanabe, Junichiro Nagai, Shigenori E. Yamauchi, Chikako Yamamoto, Yutaka Iwata, Hiroji Saji, Shigehira Toyama, Tatsuya |
| author_sort | Terada, Mitsuo |
| collection | PubMed |
| description | The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research questions (FRQs). Multiple outcomes including efficacy and safety were selected in each CQ, and then quantitative and qualitative systematic reviews were conducted to determine the strength of evidence and strength of recommendation, which was finally determined through a voting process among designated committee members. Here, we describe eight selected CQs as important updates from the previous guidelines, including novel practice-changing updates, and recommendations based on evidence that has emerged specifically from Japanese clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12282-023-01505-x. |
| format | Online Article Text |
| id | pubmed-10587293 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105872932023-10-21 The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Terada, Mitsuo Ito, Aki Kikawa, Yuichiro Koizumi, Kei Naito, Yoichi Shimoi, Tatsunori Ishihara, Mikiya Yamanaka, Takashi Ozaki, Yukinori Hara, Fumikata Nakamura, Rikiya Hattori, Masaya Miyashita, Minoru Kondo, Naoto Yoshinami, Tetsuhiro Takada, Masahiro Matsumoto, Koji Narui, Kazukata Sasada, Shinsuke Iwamoto, Takayuki Hosoda, Mitsuchika Takano, Yuko Oba, Takaaki Sakai, Hitomi Murakami, Akari Higuchi, Toru Tsuchida, Junko Tanabe, Yuko Shigechi, Tomoko Tokuda, Emi Harao, Michiko Kashiwagi, Shinichiro Mase, Junichi Watanabe, Junichiro Nagai, Shigenori E. Yamauchi, Chikako Yamamoto, Yutaka Iwata, Hiroji Saji, Shigehira Toyama, Tatsuya Breast Cancer Special Article The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a process started in 2018. The updated guidelines consist of 12 background questions (BQs), 33 clinical questions (CQs), and 20 future research questions (FRQs). Multiple outcomes including efficacy and safety were selected in each CQ, and then quantitative and qualitative systematic reviews were conducted to determine the strength of evidence and strength of recommendation, which was finally determined through a voting process among designated committee members. Here, we describe eight selected CQs as important updates from the previous guidelines, including novel practice-changing updates, and recommendations based on evidence that has emerged specifically from Japanese clinical trials. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12282-023-01505-x. Springer Nature Singapore 2023-10-07 2023 /pmc/articles/PMC10587293/ /pubmed/37804479 http://dx.doi.org/10.1007/s12282-023-01505-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Special Article Terada, Mitsuo Ito, Aki Kikawa, Yuichiro Koizumi, Kei Naito, Yoichi Shimoi, Tatsunori Ishihara, Mikiya Yamanaka, Takashi Ozaki, Yukinori Hara, Fumikata Nakamura, Rikiya Hattori, Masaya Miyashita, Minoru Kondo, Naoto Yoshinami, Tetsuhiro Takada, Masahiro Matsumoto, Koji Narui, Kazukata Sasada, Shinsuke Iwamoto, Takayuki Hosoda, Mitsuchika Takano, Yuko Oba, Takaaki Sakai, Hitomi Murakami, Akari Higuchi, Toru Tsuchida, Junko Tanabe, Yuko Shigechi, Tomoko Tokuda, Emi Harao, Michiko Kashiwagi, Shinichiro Mase, Junichi Watanabe, Junichiro Nagai, Shigenori E. Yamauchi, Chikako Yamamoto, Yutaka Iwata, Hiroji Saji, Shigehira Toyama, Tatsuya The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title_full | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title_fullStr | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title_full_unstemmed | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title_short | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition |
| title_sort | japanese breast cancer society clinical practice guidelines for systemic treatment of breast cancer, 2022 edition |
| topic | Special Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587293/ https://www.ncbi.nlm.nih.gov/pubmed/37804479 http://dx.doi.org/10.1007/s12282-023-01505-x |
| work_keys_str_mv | AT teradamitsuo thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT itoaki thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kikawayuichiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT koizumikei thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT naitoyoichi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT shimoitatsunori thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT ishiharamikiya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamanakatakashi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT ozakiyukinori thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT harafumikata thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT nakamurarikiya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT hattorimasaya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT miyashitaminoru thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kondonaoto thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yoshinamitetsuhiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT takadamasahiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT matsumotokoji thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT naruikazukata thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sasadashinsuke thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT iwamototakayuki thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT hosodamitsuchika thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT takanoyuko thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT obatakaaki thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sakaihitomi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT murakamiakari thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT higuchitoru thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tsuchidajunko thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tanabeyuko thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT shigechitomoko thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tokudaemi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT haraomichiko thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kashiwagishinichiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT masejunichi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT watanabejunichiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT nagaishigenorie thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamauchichikako thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamamotoyutaka thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT iwatahiroji thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sajishigehira thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT toyamatatsuya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT teradamitsuo japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT itoaki japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kikawayuichiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT koizumikei japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT naitoyoichi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT shimoitatsunori japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT ishiharamikiya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamanakatakashi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT ozakiyukinori japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT harafumikata japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT nakamurarikiya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT hattorimasaya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT miyashitaminoru japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kondonaoto japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yoshinamitetsuhiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT takadamasahiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT matsumotokoji japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT naruikazukata japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sasadashinsuke japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT iwamototakayuki japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT hosodamitsuchika japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT takanoyuko japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT obatakaaki japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sakaihitomi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT murakamiakari japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT higuchitoru japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tsuchidajunko japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tanabeyuko japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT shigechitomoko japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT tokudaemi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT haraomichiko japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT kashiwagishinichiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT masejunichi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT watanabejunichiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT nagaishigenorie japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamauchichikako japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT yamamotoyutaka japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT iwatahiroji japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT sajishigehira japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition AT toyamatatsuya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2022edition |